|Pharmaceuticals and the WTO TRIPS Agreement: Questions and answers (UNAIDS - WHO/EDM, 2000, 5 p.)|
The authors are very grateful to Dr J.D. Quick (WHO/EDM) and Dr M. Scholtz (WHO/HTP) for their constructive comments. Professor C.M. Correa (University of Buenos Aires), Mr A. Otten (WTO), Mr R. Wilder (WIPO) and Ms S. Zarilli (UNCTAD) are also acknowledged for their technical review and contributions to the document.
The views expressed in this document by named authors are solely the responsibility of those authors.
Suggestions and comments are welcome and should be sent to firstname.lastname@example.org
This document is not a formal publication of either UNAIDS or WHO, and all rights are reserved by the organizations. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.